Marinus Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $8,468 | $8,055 | $7,679 | $7,190 |
Gross Profit | 7,754 | 7,180 | 6,792 | 6,178 |
EBITDA | -21,080 | -31,071 | -34,192 | -37,346 |
EBIT | -31,211 | -34,323 | -37,471 | |
Net Income | -24,225 | -35,828 | -38,669 | -41,769 |
Net Change In Cash | 8,468 | 8,055 | 7,679 | 7,190 |
Free Cash Flow | -20,567 | -30,879 | -37,461 | -27,026 |
Cash | 42,184 | 64,676 | 104,253 | 120,572 |
Basic Shares | 57,229 | 57,064 | 56,851 | 56,688 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $30,989 | $25,478 | $15,345 | $1,718 |
Gross Profit | 29,055 | 25,138 | 13,867 | 1,718 |
EBITDA | -125,497 | -5,086 | -95,527 | -67,603 |
EBIT | -126,048 | -5,755 | -96,194 | -67,937 |
Net Income | -141,405 | -19,816 | -101,660 | -66,642 |
Net Change In Cash | 30,989 | 25,478 | 15,345 | 1,718 |
Cost of Revenue | 117,624 | -15,582 | 47,566 | |
Free Cash Flow | -118,120 | -114,660 | -58,366 | -60,912 |
Cash | 120,572 | 240,551 | 122,927 | 138,509 |
Basic Shares | 53,746 | 39,072 | 36,697 | 27,270 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.42 |
2024-06-30 | -$0.60 |
2024-03-31 | -$0.68 |
2023-12-31 | -$0.74 |
